Chris is a Virscio co-founder and life sciences executive and entrepreneur with over fifteen years of experience in financing, building, operating and supporting companies developing and commercializing biomedical research innovations. Chris oversees corporate strategy, business development, financing and investing activities associated with the development and commercialization of Virscio’s translational R&D platform. Under Chris’ leadership, Virscio has executed a finance and commercial plan that has positioned the company for significant and sustainable organic growth without the need for institutional financing. Prior to co-founding Virscio, Chris held positions at Accenture within the Corporate Transaction Services group where he focused on evaluating and structuring complex outsourcing, joint-venture, and equity investment transactions, and was an analyst in the Global Markets Group at JPMorgan Chase. Chris received his BBA in Finance from the University of Texas at Austin.